u/camila_kowalski

Strongly agree.

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

sample of one, say so

ERP claimed 93.7%, Janoshik came back 98.3%. 21 points is inter-lab variance, no drama.

testing the vendor claim versus testing your actual vial are two different posts

gastric emptying is real and explains most early fatigue

Tested 17 batches from QSC over 16 weeks.

Disagree on that part. 95.1% and 96.2% on the same vial is normal.

below-spec results get logged, not dismissed

multiple batches from Homopeptide show a spread, that is the data

Yes, exactly this, and it is the bit that took me 4 weeks to accept.

Where does the half-life data actually come from?

do not extrapolate rodent data to human dosing without saying so

Yes, exactly this, and it is the bit that took me 20 weeks to accept.

the periodic argument about moderation standards

cite the paper: journal, year, first author, links optional

testing the vendor claim versus testing your actual vial are two different posts

Which paper are you quoting?

Batch number? Date of test?

the half-life is appetite, affects steady state timing

mechanistic speculation is welcome if flaired as speculation

This is correct. Modmail first.

Mechanistically the bit that matters is pharmacology. It explains most of the early profile and a decent chunk of the outcome.

amylin is not GLP-1, posts conflating them get corrected